BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2025.
World J Gastroenterol. Oct 28, 2025; 31(40): 111375
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111375
Figure 2
Figure 2 Disorders occurring in both inflammatory bowel disease and steatohepatitis associated with metabolic disorders. SCFA: Short-chain fatty acid; LPS: Lipopolysaccharide; IL: Interleukin; TNF: Tumour necrosis factor; IBD: Inflammatory bowel disease; MASLD: Metabolic dysfunction-associated steatotic liver disease; E. coli: Escherichia coli; F. prausnitzii: Faecalibacterium prausnitzii.


Write to the Help Desk